Clinical trial Recruiting at 1 site Interventional Ages 50 and up

Group-based Ideomotor exercise to prevent thinking and movement decline in older adults

Official title: Effects of the Ideomotor Group Program Exercise on Cognitive Functioning, Motor Functioning and Overall Well-being in Community-Dwelling Older Adults

Run by University of Bergamo · NCT07494149 · Data updated 2026-11-12

This program will test whether a 16-week, twice-weekly group Ideomotor exercise program helps keep thinking, movement, and overall well-being better in healthy adults aged 50 and older compared with a community cognitive training group.

More Healthy Aging trials

Quick facts

Study typeInterventional
Ages50 Years and up
SexAll
Enrollment158 (estimated)
SponsorUniversity of Bergamo
Academic / other
Locations2 sites (Bergamo, Bergamo and 1 other locations)
StatusRecruiting
StartedFebruary 1, 2026
Main results expectedJuly 2026
Study endsAugust 1, 2026
Registry record updatedMarch 27, 2026
Trial IDNCT07494149 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy, community-dwelling adults aged 50 or older who can move independently, understand complex verbal instructions, have medical clearance to exercise, and can attend at least 75% of sessions.

Probably not a fit

People with severe neurological or psychiatric disorders, those unable to exercise safely or follow instructions, those who score below the program's cognitive cutoff on the FAB15, or those who cannot attend regularly are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Healthy, community-dwelling adults aged 50+ who can move independently and follow complex verbal instructions will be enrolled and randomized to either the Ideomotor exercise program or a community group cognitive training program. The active intervention runs for 16 weeks with supervised group sessions twice per week in community gym settings. Participants undergo assessments at baseline, at mid-intervention, and at program completion, and keep a diary to record falls and any adverse events. The trial excludes people with severe neurological or psychiatric conditions, those without medical clearance for exercise, and those who cannot meet attendance requirements.

Why it matters

Potential benefit: If successful, the program could help slow or prevent age-related declines in cognition and motor function and boost overall well-being through an accessible group exercise format.

How similar studies have gone: Broadly, exercise and group physical programs have shown benefits for cognition, mobility, and well-being in older adults, but the Ideomotor Program itself is relatively novel and less widely tested against cognitive training.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* At least 50 years old;
* Able to move independently;
* Live in the community;
* Demonstrated ability to comprehend complex verbal instructions.

Exclusion Criteria:

* Presence of severe neurological and psychological conditions;
* Less than 9,36 score in the FAB15;
* Lack of medical clearance to participate in an exercise program;
* Less than 75% of attendance.

Where it's running

  • Centre for Healthy Longevity
    Bergamo, Bergamo, Italy
    Recruiting
  • University of Bergamo - S. Agostino
    Bergamo, Bg, Italy
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.